Inventor
VAISBURG ARKADII
CA35 patents
⚠️ This page may combine multiple inventors who share the name “VAISBURG ARKADII”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
METHYLGENE INC
17 patentsUS7253204B2Aug 7, 2007
Inhibitors of histone deacetylase
METHYLGENE INC69 citations96
US7868205B2Jan 11, 2011
Inhibitors of histone deacetylase
METHYLGENE INC61 citations95
US7838520B2Nov 23, 2010
Inhibitors of histone deacetylase
METHYLGENE INC20 citations91
US7288567B2Oct 30, 2007
Inhibitors of histone deacetylase
METHYLGENE INC13 citations84
US7868204B2Jan 11, 2011
Inhibitors of histone deacetylase
METHYLGENE INC16 citations83
US7595343B2Sep 29, 2009
Inhibitors of histone deacetylase
METHYLGENE INC17 citations83
US7259172B2Aug 21, 2007
Inhibitors of β-lactamase
METHYLGENE INC1 citations61
US6884791B2Apr 26, 2005
Inhibitors of β-lactamase
METHYLGENE INC1 citations61
US9018378B2Apr 28, 2015
Processes and intermediates for preparing fused heterocyclic kinase inhibitors
METHYLGENE INC1 citations60
US8030344B2Oct 4, 2011
Inhibitors of histone deacetylase
METHYLGENE INC3 citations59
US7514556B2Apr 7, 2009
Inhibitors of β-lactamase
METHYLGENE INC0 citations51
US6921756B2Jul 26, 2005
Inhibitors of β-lactamase
METHYLGENE INC1 citations51
US8846927B2Sep 30, 2014
Inhibitors of protein tyrosine kinase activity
METHYLGENE INC0 citations50
US9636298B2May 2, 2017
Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
METHYLGENE INC1 citations49
US7790729B2Sep 7, 2010
Inhibitors of VEGF receptor and HGF receptor signaling
METHYLGENE INC1 citations49
US8354445B2Jan 15, 2013
Inhibitors of histone deacetylase
METHYLGENE INC0 citations48
US7772247B2Aug 10, 2010
Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptor
METHYLGENE INC1 citations48